Xinan Sheng

机构：Ministry of Education · ORCID：0000-0001-9359-0975

发表论文 438 篇 · 总被引 7064 次 · h-index 42

代表论文

• Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer (2025 · New England Journal of Medicine · 被引 74)
• Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study (2024 · Annals of Oncology · 被引 56)
• Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial (2024 · Signal Transduction and Targeted Therapy · 被引 38)
• Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights (2025 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study (2025 · Med · 被引 15)
• Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets (2025 · Nature Communications · 被引 14)